Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02427256 · ClinicalTrials.gov registry record
Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 76
- Enrollment target
NCT02427256: Completed study, sponsored by Topcon Medical Systems.
NCT02427256 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02427256 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The primary objective of this clinical study is to collect additional clinical data to support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to evaluate any adverse events found during the clinical study.
Interventions
- DEVICE Topcon Specular Microscope SP-1P
- DEVICE Konan Specular Microscope CELLCHEK XL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-02 |
What the finished NCT02427256 record still lists
NCT02427256 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Topcon Specular Microscope SP-1P is the first listed.
NCT02427256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02427256 about?
NCT02427256 is a clinical study titled "Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements". The primary objective of this clinical study is to collect additional clinical data to support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to evaluate any adverse events found during the clinical study.
What is the current status of trial NCT02427256?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2015-02. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02427256?
The interventions under investigation include: Topcon Specular Microscope SP-1P (DEVICE), Konan Specular Microscope CELLCHEK XL (DEVICE).
Who is sponsoring clinical trial NCT02427256?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia